- Energizer Holdings to acquire feminine hygiene business from J&J Family of Consumer Cos.
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- McNeil unveils 'Smiling it Forward' campaign in support of Tylenol
- Energizer completes acquisition of feminine hygiene business from J&J Family of Consumer Cos.
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
NEW YORK — Johnson & Johnson is shopping its women's health unit, according to a report Friday in The Wall Street Journal, which suggested that the business no longer coincided with J&J's "growth priorities."
The brands managed by the unit include intimacy health KY and women's personal care brands, o.b. tampons and Stayfree and Carefree pads.
Recent brands sold by J&J have included e.p.t. pregnancy tests, Monistat and Rolaids.
The Wall Street Journal projected that more consumer brands considered non-core to J&J's growth strategies will be jettisoned as well, potentially including Band-Aid, Listerine, Neutrogena and even Tylenol.
But the company will not be exiting the OTC arena altogether, the report suggested, citing J&J's ongoing interest in eyecare company Bausch & Lomb.
Find us on Facebook for even more insight, analysis and the latest in drug store news.